ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

April 16, 2004

John Montgomery Named to Replace Harold Amos On Cancer Panel

April 8, 1983

Jackson Lab Win $9.5 Mil. Grant; Others Named

October 5, 1990

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000